The Silk Road Single-Domain Antibodies Industry Innovation Alliance has successfully concluded

The four-day " Silk Road Single-Domain Antibodies Industry Innovation Alliance" concluded in Inner Mongolia from August 12th to 15th, 2025. This conference brought together over 120 experts and scholars from 47 institutions in China, Mongolia, Kazakhstan, Belgium and other countries. Experts from Angel Holding Group were also invited to attend and signed multiple research and development cooperation agreements on the spot.

The conference innovatively combined academic discussions with ecological investigations. On the first day, it organized the attending experts to cross the Badain Jaran Desert to conduct on-site investigations of the living environment of Bactrian camels.

​​​​​​​​​​​​​​

On August 14th, at the round-table conference, the "Silk Road Single-Domain Antibodies Industry Innovation Alliance" was jointly initiated by the China-Mongolia Joint Laboratory of Biopolymers, the National Medical University of Mongolia, the Institute of Livestock Research of Kazakhstan and other institutions. The alliance will focus on tackling key problems：

• Diagnosis and treatment of major respiratory infectious diseases
• Food safety testing and evaluation
• AI technology builds a nanobody design platform

This meeting enhanced the brand influence and market trust of Angel Holding Group. At the same time, it was very helpful for improving the R&D efficiency of Angel Holding Group in the field of biotechnology and shortening the new product development cycle.